These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
513 related items for PubMed ID: 18585502
1. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB. Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502 [Abstract] [Full Text] [Related]
2. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, Keren G, George J. Int J Cardiol; 2007 Apr 25; 117(2):198-203. PubMed ID: 16887211 [Abstract] [Full Text] [Related]
3. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R. Am Heart J; 2006 Oct 25; 152(4):697-704. PubMed ID: 16996841 [Abstract] [Full Text] [Related]
4. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon. Aharinejad S, Andrukhova O, Lucas T, Zuckermann A, Wieselthaler G, Wolner E, Grimm M. Ann Thorac Surg; 2008 Jul 25; 86(1):109-14; discussion 114. PubMed ID: 18573408 [Abstract] [Full Text] [Related]
5. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. Nikolaev VO, Boivin V, Störk S, Angermann CE, Ertl G, Lohse MJ, Jahns R. J Am Coll Cardiol; 2007 Jul 31; 50(5):423-31. PubMed ID: 17662395 [Abstract] [Full Text] [Related]
10. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA. Basic Res Cardiol; 2011 Jan 31; 106(1):25-35. PubMed ID: 20957484 [Abstract] [Full Text] [Related]
12. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T. Nat Med; 2003 Dec 31; 9(12):1477-83. PubMed ID: 14595408 [Abstract] [Full Text] [Related]
13. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Leuschner F, Li J, Göser S, Reinhardt L, Ottl R, Bride P, Zehelein J, Pfitzer G, Remppis A, Giannitsis E, Katus HA, Kaya Z. Eur Heart J; 2008 Aug 31; 29(16):1949-55. PubMed ID: 18556712 [Abstract] [Full Text] [Related]
14. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U. J Mol Cell Cardiol; 2001 Aug 31; 33(8):1515-25. PubMed ID: 11448139 [Abstract] [Full Text] [Related]